The pace of change in cardiometabolic medicine is accelerating. Ian Neeland, MD, breaks down the latest innovations in incretin therapies, from oral medications to cutting-edge combinations, and what they mean for weight loss, heart health, and long-term patient care.Learn more about Daniel Simon, MDLearn more about Ian Neeland, MDView our Science@UH video podcast on YouTubeLearn more about the University Hospitals Research & Education Institute
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Science@UH
Ovarian Tissue Transplants Provide New Hope to Women with Ovarian Insufficiency
Protecting Memory After TBI and in Alzheimer’s – New Hope from 15-PGDH
Common Doesn’t Mean Normal: Rethinking Urinary Incontinence Care
From Lab to Life: Expanding the Power of CAR T-Cells
Get summaries like this every morning.
Free AI-powered recaps of Science@UH and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.